Share ownership Healwell AI Inc.

AIDX

CA42249X1006

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 16:00:00 2025-11-14 EST			5-day change	1st Jan Change
1.150 ^CAD	-3.36%		-11.54%	-45.50%

11-07	Healwell AI Inc., Q3 2025 Earnings Call, Nov 07, 2025
11-06	Healwell AI Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI

Share class: Healwell AI Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	30,800,000	0	0	54.36 %
Stock B	1	168,829,039	108,518,751 ( 64.28 %)	0

Major shareholders: Healwell AI Inc.

Name	Equities	%	Valuation
WELL HEALTH TECHNOLOGIES CORP. 34.78 %	97,223,161	34.78 %	104 M $
Ian McCrae 12.75 %	35,643,478	12.75 %	38 M $
Samuel Englebardt 4.115 %	11,504,100	4.115 %	12 M $
George Christodoulou 0.7579 %	2,119,022	0.7579 %	2 M $
Alexander Dobranowski 0.7203 %	2,013,660	0.7203 %	2 M $
Impactreneur Capital Corp. 0.5299 %	1,481,544	0.5299 %	2 M $
Anthony Lam 0.0393 %	110,000	0.0393 %	117 700 $
Blake Corbet 0.0145 %	40,627	0.0145 %	43 471 $
John Kim 0.0125 %	35,000	0.0125 %	37 450 $
Erik Danudjaja 0.0112 %	31,250	0.0112 %	33 438 $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
WELL HEALTH TECHNOLOGIES CORP. 85.56 %	30,800,000	85.56 %	33 M $

Breakdown by shareholder type

WELL Health Technologies Corp.	45.79%
Individuals	18.42%
Other	0.53%
Unknown	35.25%

Based on 1000 largest holdings

Geographical origin of shareholders

Canada	46.32%
Individuals	18.42%

Based on 1000 largest holdings

Healwell Al Inc. is a Canada-based healthcare artificial intelligence (AI) company focused on preventative care. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The Company's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere divisions. The Company's AutoScribe platform is an advanced AI-powered ambient scribe solution. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.

Employees

350

Sector

Advanced Medical Equipment & Technology

Calendar

03-25 - Q4 2025 Earnings Release (Projected)

More about the company